
Sign up to save your podcasts
Or
Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer.
CME information and select publications here.
4.9
5656 ratings
Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer.
CME information and select publications here.
136 Listeners
17 Listeners
30 Listeners
13 Listeners
71 Listeners
13 Listeners
76 Listeners
0 Listeners
323 Listeners
116 Listeners
501 Listeners
57 Listeners
3,334 Listeners
200 Listeners
44 Listeners
21 Listeners
366 Listeners
185 Listeners
42 Listeners
0 Listeners